RxDoctor Payments Data

Jill Stephens

Family · Ocala, FLNPI 1437582392

Payments from drug & device makers

$1,293in general payments, 2019–2025

Across 73 payments — averaging $17.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$447
  • Novo Nordisk$269
  • Amgen$106
  • Lilly USA, LLC$105
  • Novartis$50
  • Exact Sciences$48
  • plus $268 from 11 others

What the payments were for

  • Food & beverage$1,293100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,293 in reported general payments places this provider in the 70th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Medicare billing

Part B allowed, 2024
$27,194
Medicare patients
164
Services billed
311

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide38$66,657
RybelsusSemaglutide25$34,460
JardianceEmpagliflozin22$34,389
TrulicityDulaglutide13$28,134
JanuviaSitagliptin Phosphate19$17,876
UbrelvyUbrogepant12$13,524
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$10,076
Rosuvastatin Calcium95$1,287
Levothyroxine Sodium110$1,238
Albuterol Sulfate HfaAlbuterol Sulfate42$1,203
Omeprazole65$1,203
SynthroidLevothyroxine Sodium18$1,008
Atorvastatin Calcium115$899
Acarbose11$832
Gabapentin50$823

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$269$101,11763 claims
Lilly USA, LLCTrulicity$105$28,13413 claims
MerckJanuvia$16$17,87619 claims
AbbVieUbrelvy, Synthroid$447$14,53230 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 14,618 family providers in Florida.

Other family in Ocala

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →